We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DRI:NYSEDarden Restaurants, Inc. Analysis

Data as of 2026-06-13 - not real-time

$211.47

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Darden Restaurants is trading at $211.47, comfortably above its 20‑day SMA of 200.6 and showing a bullish MACD crossover (MACD line 2.17 above signal 1.00). The RSI sits at 64.9, indicating momentum without being overbought, while price remains between a solid support at $189.97 and resistance near $214.14. Fundamentally, the chain delivers a 5.9% revenue growth rate, a remarkable 51.5% ROE, and a 2.84% dividend yield supported by a 62% payout ratio and strong free cash flow. Analyst consensus is bullish with a median target of $230, suggesting roughly a 7% upside from current levels. Upcoming fiscal‑2026 earnings on June 25 provide a near‑term catalyst, but the overall technical set‑up and modest upside keep the stock in a favorable position.
The high debt‑to‑equity ratio (≈388) and a 30‑day volatility of 26% inject financial caution, yet the low beta (~0.35) and stable volume mitigate market‑wide risk. The consumer‑cyclical exposure means performance will track discretionary spending trends, but the diversified brand portfolio and consistent dividend payments underpin long‑term resilience. Investors should weigh the modest upside against the elevated leverage when defining their horizon.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish MACD and RSI below overbought levels
  • Upcoming earnings release as a catalyst
  • Price near resistance with limited short‑term upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst price targets indicating ~7% upside
  • Strong dividend yield and sustainable payout
  • Robust ROE and steady revenue growth

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified restaurant portfolio with brand depth
  • High ROE and consistent cash flow generation
  • Dividend compounding potential despite high leverage

Key Metrics & Analysis

Financial Health

Revenue Growth5.90%
Profit Margin8.66%
P/E Ratio22.3
ROE51.54%
ROA7.26%
Debt/Equity387.68
P/B Ratio11.5
Op. Cash Flow$1.7B
Free Cash Flow$678.2M

Technical Analysis

TrendBullish
RSI64.9
Support$189.97
Resistance$214.14
MA 20$200.61
MA 50$198.24
MA 200$195.78
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value$31.78
Target Price$226.23
Upside/Downside6.98%
GradeUndervalued
TypeBlend
Dividend Yield2.84%

Risk Assessment

Beta0.35
Volatility26.39%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.